These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 25047500)
41. Targeting cellular memory to reprogram the epigenome, restore potential, and improve somatic cell nuclear transfer. Eilertsen KJ; Power RA; Harkins LL; Misica P Anim Reprod Sci; 2007 Mar; 98(1-2):129-46. PubMed ID: 17166676 [TBL] [Abstract][Full Text] [Related]
42. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells. Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168 [TBL] [Abstract][Full Text] [Related]
43. Early epigenetic cancer decisions. Martín-Lorenzo A; Gonzalez-Herrero I; Rodríguez-Hernández G; García-Ramírez I; Vicente-Dueñas C; Sánchez-García I Biol Chem; 2014 Nov; 395(11):1315-20. PubMed ID: 25205718 [TBL] [Abstract][Full Text] [Related]
44. Common themes of dedifferentiation in somatic cell reprogramming and cancer. Daley GQ Cold Spring Harb Symp Quant Biol; 2008; 73():171-4. PubMed ID: 19150965 [TBL] [Abstract][Full Text] [Related]
45. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons. Qi SD; Smith PD; Choong PF ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845 [TBL] [Abstract][Full Text] [Related]
46. Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells. Scaffidi P; Misteli T Cold Spring Harb Symp Quant Biol; 2010; 75():251-8. PubMed ID: 21047903 [TBL] [Abstract][Full Text] [Related]
47. Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology. Laplane L; Beke A; Vainchenker W; Solary E Stem Cells; 2015 Oct; 33(10):2887-92. PubMed ID: 26179060 [TBL] [Abstract][Full Text] [Related]
48. Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance. Fatma H; Maurya SK; Siddique HR Semin Cancer Biol; 2022 Aug; 83():166-176. PubMed ID: 33220458 [TBL] [Abstract][Full Text] [Related]
49. Induced Pluripotent Stem Cells from Cancer-Resistant Naked Mole-Rats. Miura K; Oiwa Y; Kawamura Y Adv Exp Med Biol; 2021; 1319():329-339. PubMed ID: 34424523 [TBL] [Abstract][Full Text] [Related]
53. Epigenetic memory in the context of nuclear reprogramming and cancer. Halley-Stott RP; Gurdon JB Brief Funct Genomics; 2013 May; 12(3):164-73. PubMed ID: 23585580 [TBL] [Abstract][Full Text] [Related]
54. Cellular reprogramming technology for dissecting cancer epigenome in vivo. Ito K; Yamada Y Epigenomics; 2017 Jul; 9(7):997-1011. PubMed ID: 28651445 [TBL] [Abstract][Full Text] [Related]